AAPS Recognizes Excellence in Publishing with Three Manuscript Awards
Research ranges from novel self-emulsifying drug formulations to pharmacokinetic biomarkers in cancer patients to NextGen 3D printing of immediate release tablets
The American Association of Pharmaceutical Scientists (AAPS) recognizes three award-winning manuscripts from three research journals: The AAPS Journal, AAPS PharmSciTech, and Pharmaceutical Research. Each award aims to recognize outstanding contributions to the pharmaceutical sciences. The winning manuscripts were selected based on the article type (original research and reviews) and potential impact in the field (number of citations and downloads).
The AAPS PharmSciTech High Impact Article Award
This award recognizes outstanding achievement in pharmaceutical technologies, as demonstrated in “Development of Solid Self-Emulsifying (SEDDS) Formulation for Improving the Oral Bioavailability of Erlotinib,” by Yong and colleagues. The authors conducted morphological analysis, solid state characterization, in vitro drug release, and in vivo pharmacokinetic studies to clearly support their conclusion. The following authors have received this honor for their work: Chul Soon Yong, Jong Oh Kim, Duy Hieu Truong, Tuan Hiep Tran, Thiruganesh Ramasamy, Ju Yeon Choi, Hee Hyun Lee, and Cheol MoonHan-Gon Choi.
The AAPS Journal High Impact Article Award
This award recognizes outstanding achievement in pharmaceutical sciences, as demonstrated in “Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: A Pooled Population Pharmacokinetic Analysis,” by Salem and colleagues. This manuscript was selected for its outstanding quality and originality. The following authors have received this honor: Ahmed Hamed Salem, Aksana K. Jones, Kevin J. Freise, Suresh K. Agarwal, Rod A. Humerickhouse, and Shekman L. Wong.
The AAPS Pharmaceutical Research Meritorious Manuscript Award
This award recognizes outstanding achievement in pharmaceutical sciences as demonstrated in “A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets,” by Mohamed A. Alhnan, Tochukwu C. Okwuosa, Dominika Stefaniak, Basel Arafat, Abdullah Isreb, and Ka-Wai Wan. The study found that combining PVP with FDM 3D Printing at low temperatures holds potential for personalized drug manufacturing.
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Visit www.aaps.org today and follow us on Twitter and Facebook, hashtags #AAPS2018 and #PharmSci360.